NanoViricides: Pioneering the Future of Antiviral Therapies SHELTON, CT, November 2024 – NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage biotechnology company specializing...
Despite global efforts to shift towards sustainable energy sources, the persistent rise in fossil fuel consumption poses a significant challenge to the...